Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of SGLT

The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG 1] a:T FIG. 1A | 9000- o 5mg/mL Nanosuspension o 8000- o 4x25mg tablets E 7000- A 100mg tablet 6000- c_ 5000 o 30000E 2000 80 48 1216 20 24...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	JOSEPH, THOMAS C, WANG, WENHUA, OUTWIN, TODD
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!